BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 37612380)

  • 1. Primary aldosteronism: molecular medicine meets public health.
    Azizan EAB; Drake WM; Brown MJ
    Nat Rev Nephrol; 2023 Dec; 19(12):788-806. PubMed ID: 37612380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Diagnosis and treatment outcome in primary aldosteronism based on a retrospective analysis of 187 cases].
    Szücs N; Gláz E; Varga I; Tóth M; Kiss R; Patócs A; Jakab C; Perner F; Járay J; Horányi J; Dabasi G; Molnár F; Major L; Füto L; Rácz K; Tulassay Z
    Orv Hetil; 2006 Jan; 147(2):51-9. PubMed ID: 16509213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis and treatment of primary aldosteronism.
    Reincke M; Bancos I; Mulatero P; Scholl UI; Stowasser M; Williams TA
    Lancet Diabetes Endocrinol; 2021 Dec; 9(12):876-892. PubMed ID: 34798068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unique cases of unilateral hyperaldosteronemia due to multiple adrenocortical micronodules, which can only be detected by selective adrenal venous sampling.
    Omura M; Sasano H; Fujiwara T; Yamaguchi K; Nishikawa T
    Metabolism; 2002 Mar; 51(3):350-5. PubMed ID: 11887172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Update on the Genetics of Primary Aldosteronism and Aldosterone-Producing Adenomas.
    Pitsava G; Faucz FR; Stratakis CA; Hannah-Shmouni F
    Curr Cardiol Rep; 2022 Sep; 24(9):1189-1195. PubMed ID: 35841527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel genetic determinants of adrenal aldosterone regulation.
    Azizan EA; Brown MJ
    Curr Opin Endocrinol Diabetes Obes; 2016 Jun; 23(3):209-17. PubMed ID: 26992195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcriptome Pathway Analysis of Pathological and Physiological Aldosterone-Producing Human Tissues.
    Zhou J; Lam B; Neogi SG; Yeo GS; Azizan EA; Brown MJ
    Hypertension; 2016 Dec; 68(6):1424-1431. PubMed ID: 27777363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disordered CYP11B2 Expression in Primary Aldosteronism.
    Gomez-Sanchez CE; Kuppusamy M; Reincke M; Williams TA
    Horm Metab Res; 2017 Dec; 49(12):957-962. PubMed ID: 29202495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High rate of detection of primary aldosteronism, including surgically treatable forms, after 'non-selective' screening of hypertensive patients.
    Stowasser M; Gordon RD; Gunasekera TG; Cowley DC; Ward G; Archibald C; Smithers BM
    J Hypertens; 2003 Nov; 21(11):2149-57. PubMed ID: 14597859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathology of Aldosterone Biosynthesis and its Action.
    Gao X; Yamazaki Y; Tezuka Y; Omata K; Ono Y; Morimoto R; Nakamura Y; Suzuki T; Satoh F; Sasano H
    Tohoku J Exp Med; 2021 May; 254(1):1-15. PubMed ID: 34011803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathogenesis and treatment of primary aldosteronism.
    Zennaro MC; Boulkroun S; Fernandes-Rosa FL
    Nat Rev Endocrinol; 2020 Oct; 16(10):578-589. PubMed ID: 32724183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary aldosteronism.
    Gordon RD
    J Endocrinol Invest; 1995; 18(7):495-511. PubMed ID: 9221268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of a test using saralasin to differentiate primary aldosteronism due to an aldosterone-producing adenoma from idiopathic hyperaldosteronism.
    Brown RD; Kem DC; Hogan MJ; Hegstad RL
    Metabolism; 1984 Aug; 33(8):734-8. PubMed ID: 6748946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adrenal Anion Channels: New Roles in Zona Glomerulosa Physiology and in the Pathophysiology of Primary Aldosteronism.
    Stölting G; Scholl UI
    Handb Exp Pharmacol; 2024; 283():59-79. PubMed ID: 37495852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence, diagnosis and outcomes of treatment for primary aldosteronism.
    Yang Y; Reincke M; Williams TA
    Best Pract Res Clin Endocrinol Metab; 2020 Mar; 34(2):101365. PubMed ID: 31837980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Colocalization of Wnt/β-Catenin and ACTH Signaling Pathways and Paracrine Regulation in Aldosterone-producing Adenoma.
    De Sousa K; Abdellatif AB; Giscos-Douriez I; Meatchi T; Amar L; Fernandes-Rosa FL; Boulkroun S; Zennaro MC
    J Clin Endocrinol Metab; 2022 Jan; 107(2):419-434. PubMed ID: 34570225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Biology of Normal Zona Glomerulosa and Aldosterone-Producing Adenoma: Pathological Implications.
    Seccia TM; Caroccia B; Gomez-Sanchez EP; Gomez-Sanchez CE; Rossi GP
    Endocr Rev; 2018 Dec; 39(6):1029-1056. PubMed ID: 30007283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hyperaldosteronism].
    Scholl UI
    Internist (Berl); 2021 Mar; 62(3):245-251. PubMed ID: 33599784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Old and new genes in primary aldosteronism.
    Boulkroun S; Fernandes-Rosa FL; Zennaro MC
    Best Pract Res Clin Endocrinol Metab; 2020 Mar; 34(2):101375. PubMed ID: 32007424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overview of aldosterone-related genetic syndromes and recent advances.
    Zennaro MC; Fernandes-Rosa FL; Boulkroun S
    Curr Opin Endocrinol Diabetes Obes; 2018 Jun; 25(3):147-154. PubMed ID: 29432258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.